{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:48:11Z","timestamp":1787316491116,"version":"build-2736575974"},"reference-count":53,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T00:00:00Z","timestamp":1668643200000},"content-version":"vor","delay-in-days":1296,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1AI113130"],"award-info":[{"award-number":["RO1AI113130"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1111\/ajt.15216","type":"journal-article","created":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T08:34:58Z","timestamp":1544776498000},"page":"1305-1314","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Dual blockade of the PI3K\/Akt\/mTOR pathway inhibits posttransplant Epstein-Barr virus B cell lymphomas and promotes allograft survival"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6551-493X","authenticated-orcid":false,"given":"Adam X.","family":"Sang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marla C.","family":"McPherson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey T.","family":"Ivison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiumei","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Rigdon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos O.","family":"Esquivel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheri M.","family":"Krams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia M.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/ajt.15216_bib1","doi-asserted-by":"crossref","first-page":"15088","DOI":"10.1038\/nrdp.2015.88","article-title":"Post-transplant lymphoproliferative disorders","volume":"28","author":"Dharnidharka","year":"2016","journal-title":"Nat Rev Dis Primer."},{"issue":"6","key":"10.1111\/ajt.15216_bib2","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1200\/JCO.2009.25.4961","article-title":"Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern era","volume":"28","author":"Evens","year":"2010","journal-title":"J Clin Oncol."},{"issue":"3","key":"10.1111\/ajt.15216_bib3","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11899-013-0162-5","article-title":"Post-transplant lymphoproliferative disease (PTLD): risk factors, diagnosis, and current treatment strategies","volume":"8","author":"Al-Mansour","year":"2013","journal-title":"Curr Hematol Malig Rep."},{"issue":"3","key":"10.1111\/ajt.15216_bib4","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/00007890-199508000-00010","article-title":"Rapamycin, a potent immunosuppressive drug, causes programmed cell death in B lymphoma cells","volume":"60","author":"Muthukkumar","year":"1995","journal-title":"Transplantation."},{"issue":"8","key":"10.1111\/ajt.15216_bib5","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1111\/ajt.12328","article-title":"PI3K\u03b4 inhibition augments the efficacy of rapamycin in suppressing proliferation of epstein\u2212barr virus (EBV)+ B cell lymphomas: PI3K\u03b4, mTOR and EBV+ PTLD","volume":"13","author":"Furukawa","year":"2013","journal-title":"Am J Transplant."},{"issue":"4","key":"10.1111\/ajt.15216_bib6","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/ajt.12137","article-title":"Syk-induced phosphatidylinositol-3-kinase activation in Epstein-Barr virus posttransplant lymphoproliferative disorder: role of Syk-induced PI3K in EBV+ PTLD","volume":"13","author":"Hatton","year":"2013","journal-title":"Am J Transplant."},{"issue":"12","key":"10.1111\/ajt.15216_bib7","doi-asserted-by":"crossref","first-page":"8225","DOI":"10.4049\/jimmunol.179.12.8225","article-title":"Latent membrane protein 1 of EBV activates phosphatidylinositol 3-kinase to induce production of IL-10","volume":"179","author":"Lambert","year":"2007","journal-title":"J Immunol."},{"issue":"8","key":"10.1111\/ajt.15216_bib8","doi-asserted-by":"crossref","first-page":"e42610","DOI":"10.1371\/journal.pone.0042610","article-title":"Src kinase and Syk activation initiate PI3K signaling by a chimeric latent membrane protein 1 in Epstein-Barr virus (EBV)+ B cell lymphomas","volume":"7","author":"Hatton","year":"2012","journal-title":"PLoS ONE."},{"issue":"3","key":"10.1111\/ajt.15216_bib9","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1399-3046.2012.01656.x","article-title":"Emerging therapeutic strategies for Epstein-Barr virus+ post-transplant lymphoproliferative disorder: emerging therapeutic strategies for EBV+PTLD","volume":"16","author":"Hatton","year":"2012","journal-title":"Pediatr Transplant."},{"issue":"8","key":"10.1111\/ajt.15216_bib10","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1097\/01.tp.0000260142.38619.9c","article-title":"Rapamycin inhibits proliferation of Epstein-Barr virus positive B-cell lymphomas through modulation of cell-cycle protein expression","volume":"83","author":"Vaysberg","year":"2007","journal-title":"Transplantation."},{"issue":"5","key":"10.1111\/ajt.15216_bib11","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1053\/j.ajkd.2006.01.029","article-title":"Sirolimus-induced remission of posttransplantation lymphoproliferative disorder","volume":"47","author":"Cullis","year":"2006","journal-title":"Am J Kidney Dis."},{"issue":"6","key":"10.1111\/ajt.15216_bib12","doi-asserted-by":"crossref","first-page":"604.e1","DOI":"10.1016\/j.cmi.2015.02.002","article-title":"Current preventive strategies and management of Epstein\u2013Barr virus-related post-transplant lymphoproliferative disease in solid organ transplantation in Europe. Results of the ESGICH Questionnaire-based Cross-sectional Survey","volume":"21","author":"San-Juan","year":"2015","journal-title":"Clin Microbiol Infect."},{"issue":"11","key":"10.1111\/ajt.15216_bib13","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1111\/j.1600-6143.2007.01972.x","article-title":"Dissociation of depletional induction and posttransplant lymphoproliferative disease in kidney recipients treated with alemtuzumab","volume":"7","author":"Kirk","year":"2007","journal-title":"Am J Transplant."},{"issue":"1","key":"10.1111\/ajt.15216_bib14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/TP.0b013e31823ae7db","article-title":"Association of immunosuppressive maintenance regimens with posttransplant lymphoproliferative disorder in kidney transplant recipients","volume":"93","author":"Sampaio","year":"2012","journal-title":"Transplantation."},{"issue":"2","key":"10.1111\/ajt.15216_bib15","doi-asserted-by":"crossref","first-page":"e1000038","DOI":"10.1371\/journal.pbio.1000038","article-title":"Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2","volume":"7","author":"Feldman","year":"2009","journal-title":"PLoS Biol."},{"issue":"12","key":"10.1111\/ajt.15216_bib16","doi-asserted-by":"crossref","first-page":"8023","DOI":"10.1074\/jbc.M900301200","article-title":"An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1","volume":"284","author":"Thoreen","year":"2009","journal-title":"J Biol Chem."},{"key":"10.1111\/ajt.15216_bib17","unstructured":"Carracedo A, Ma L, Teruya-Feldstein J, et al. Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer. J Clin Invest. http:\/\/www.jci.org\/articles\/view\/34739. Accessed July 9, 2017"},{"issue":"13","key":"10.1111\/ajt.15216_bib18","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1038\/sj.onc.1209990","article-title":"Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism","volume":"26","author":"Wan","year":"2007","journal-title":"Oncogene."},{"issue":"1","key":"10.1111\/ajt.15216_bib19","first-page":"19","article-title":"Physiological regulation of Akt activity and stability","volume":"2","author":"Liao","year":"2010","journal-title":"Am J Transl Res."},{"issue":"2","key":"10.1111\/ajt.15216_bib20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.molcel.2006.03.029","article-title":"Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt\/PKB","volume":"22","author":"Sarbassov","year":"2006","journal-title":"Mol Cell."},{"issue":"9","key":"10.1111\/ajt.15216_bib21","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.4049\/jimmunol.158.9.4045","article-title":"Involvement of IL-10 in the autonomous growth of EBV-transformed B cell lines","volume":"158","author":"Beatty","year":"2007","journal-title":"J Immunol."},{"issue":"15","key":"10.1111\/ajt.15216_bib22","first-page":"4472","article-title":"Rapamycin inhibits the interleukin 10 signal transduction pathway and the growth of Epstein Barr virus B-cell lymphomas","volume":"63","author":"Nepomuceno","year":"2003","journal-title":"Cancer Res."},{"issue":"5","key":"10.1111\/ajt.15216_bib23","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1600-6143.2011.03958.x","article-title":"Differential expression of MicroRNAs during allograft rejection: microRNAs in allograft rejection","volume":"12","author":"Wei","year":"2012","journal-title":"Am J Transplant."},{"issue":"3","key":"10.1111\/ajt.15216_bib24","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/TP.0000000000001345","article-title":"Absence of miR-182 augments cardiac allograft survival","volume":"101","author":"Wei","year":"2017","journal-title":"Transplantation."},{"issue":"7","key":"10.1111\/ajt.15216_bib25","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/sim.3005","article-title":"Quantifying synergism\/antagonism using nonlinear mixed-effects modeling: a simulation study","volume":"27","author":"Boik","year":"2008","journal-title":"Stat Med."},{"issue":"1","key":"10.1111\/ajt.15216_bib26","doi-asserted-by":"crossref","DOI":"10.18637\/jss.v067.i01","article-title":"Fitting linear mixed-effects models using lme4","volume":"67","author":"Bates","year":"2015","journal-title":"J Stat Softw."},{"issue":"3","key":"10.1111\/ajt.15216_bib27","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2307\/2533558","article-title":"Small sample inference for fixed effects from restricted maximum likelihood","volume":"53","author":"Kenward","year":"1997","journal-title":"Biometrics."},{"key":"10.1111\/ajt.15216_bib28","unstructured":"Kuznetsova A, Brockhoff P, Christensen RHB. ImerTest: Tests in linear effects models (version 2.0-29). Available: https:\/\/cran.r-project.org\/web\/packages\/ImerTest\/index.html"},{"issue":"437","key":"10.1111\/ajt.15216_bib29","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/01621459.1997.10473627","article-title":"Multiple testing of general contrasts using logical constraints and correlations","volume":"92","author":"Westfall","year":"1997","journal-title":"J Am Stat Assoc."},{"issue":"3","key":"10.1111\/ajt.15216_bib30","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/bimj.200810425","article-title":"Simultaneous inference in general parametric models","volume":"50","author":"Hothorn","year":"2008","journal-title":"Biom J Biom Z."},{"issue":"43","key":"10.1111\/ajt.15216_bib31","doi-asserted-by":"crossref","first-page":"37368","DOI":"10.1074\/jbc.M111.255125","article-title":"Syk activation of phosphatidylinositol 3-kinase\/Akt prevents HtrA2-dependent loss of X-linked inhibitor of apoptosis protein (XIAP) to promote survival of Epstein-Barr virus+ (EBV+) B cell lymphomas","volume":"286","author":"Hatton","year":"2011","journal-title":"J Biol Chem."},{"issue":"4","key":"10.1111\/ajt.15216_bib32","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1600-6143.2011.03470.x","article-title":"Improved survival with recent post-transplant lymphoproliferative disorder (PTLD) in children with kidney transplants: improved survival with recent post-transplant lymphoproliferative disorder","volume":"11","author":"Dharnidharka","year":"2011","journal-title":"Am J Transplant."},{"issue":"8","key":"10.1111\/ajt.15216_bib33","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1097\/TP.0b013e3182664042","article-title":"Increased infection rate after preemptive rituximab treatment for Epstein-Barr virus reactivation after allogeneic hematopoietic stem-cell transplantation","volume":"94","author":"Petropoulou","year":"2012","journal-title":"Transplant J."},{"issue":"12","key":"10.1111\/ajt.15216_bib34","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.4161\/cbt.7.12.6944","article-title":"Overcoming mTOR inhibition-induced paradoxical activation of survival signaling pathways enhances mTOR inhibitors\u2019 anticancer efficacy","volume":"7","author":"Wang","year":"2008","journal-title":"Cancer Biol Ther."},{"issue":"1","key":"10.1111\/ajt.15216_bib35","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1476-4598-11-85","article-title":"Combined targeting of AKT and mTOR synergistically inhibits proliferation of hepatocellular carcinoma cells","volume":"11","author":"Grabinski","year":"2012","journal-title":"Mol Cancer."},{"issue":"12","key":"10.1111\/ajt.15216_bib36","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.7150\/jca.12452","article-title":"Vertical targeting of AKT and mTOR as well as dual targeting of AKT and MEK signaling is synergistic in hepatocellular carcinoma","volume":"6","author":"Ewald","year":"2015","journal-title":"J Cancer."},{"issue":"1","key":"10.1111\/ajt.15216_bib37","article-title":"PDK1-mTOR signaling pathway inhibitors reduce cell proliferation in MK2206 resistant neuroblastoma cells","volume":"15","author":"Qi","year":"2015","journal-title":"Cancer Cell Int [Internet]"},{"issue":"15","key":"10.1111\/ajt.15216_bib38","doi-asserted-by":"crossref","first-page":"4308","DOI":"10.1016\/j.bmcl.2010.05.099","article-title":"Allosteric and ATP-competitive kinase inhibitors of mTOR for cancer treatment","volume":"20","author":"Garc\u00eda-Echeverr\u00eda","year":"2010","journal-title":"Bioorg Med Chem Lett."},{"issue":"2","key":"10.1111\/ajt.15216_bib39","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1182\/blood-2011-04-346601","article-title":"Dual mTORC1\/mTORC2 inhibition diminishes Akt activation and induces Puma-dependent apoptosis in lymphoid malignancies","volume":"119","author":"Gupta","year":"2012","journal-title":"Blood."},{"issue":"8","key":"10.1111\/ajt.15216_bib40","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1073\/pnas.080068597","article-title":"The immunosuppressive macrolide RAD inhibits growth of human Epstein-Barr virus-transformed B lymphocytes in vitro and in vivo: a potential approach to prevention and treatment of posttransplant lymphoproliferative disorders","volume":"97","author":"Majewski","year":"2000","journal-title":"Proc Natl Acad Sci."},{"issue":"9","key":"10.1111\/ajt.15216_bib41","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1034\/j.1600-6143.2002.20902.x","article-title":"Cardiovascular toxicities of immunosuppressive agents","volume":"2","author":"Miller","year":"2002","journal-title":"Am J Transplant."},{"issue":"Supplement","key":"10.1111\/ajt.15216_bib42","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1097\/TP.0b013e3181a05b7a","article-title":"Management of side effects of sirolimus therapy","volume":"87","author":"Stallone","year":"2009","journal-title":"Transplantation."},{"issue":"8","key":"10.1111\/ajt.15216_bib43","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.2337\/db13-0106","article-title":"Evidence for rapamycin toxicity in pancreatic \u03b2-cells and a review of the underlying molecular mechanisms","volume":"62","author":"Barlow","year":"2013","journal-title":"Diabetes."},{"issue":"1","key":"10.1111\/ajt.15216_bib44","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1742-481X.2012.00950.x","article-title":"Effects of immunosuppressive therapy on wound healing","volume":"10","author":"Bootun","year":"2013","journal-title":"Int Wound J."},{"issue":"9","key":"10.1111\/ajt.15216_bib45","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1097\/00007890-200405150-00002","article-title":"Rapamycin protects allografts from rejection while simultaneously attacking tumors in immunosuppressed mice","volume":"77","author":"Koehl","year":"2004","journal-title":"Transplantation."},{"issue":"10","key":"10.1111\/ajt.15216_bib46","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1097\/01.TP.0000063934.89714.19","article-title":"Immunosuppressive TOR kinase inhibitor everolimus (RAD) suppresses growth of cells derived from posttransplant lymphoproliferative disorder at allograft-protecting doses","volume":"75","author":"Majewski","year":"2003","journal-title":"Transplantation."},{"issue":"1","key":"10.1111\/ajt.15216_bib47","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.critrevonc.2004.09.009","article-title":"Rapamycin: an anti-cancer immunosuppressant?","volume":"56","author":"Law","year":"2005","journal-title":"Crit Rev Oncol Hematol."},{"issue":"3","key":"10.1111\/ajt.15216_bib48","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1042\/BJ20112092","article-title":"PI3K signalling in B- and T-lymphocytes: new developments and therapeutic advances","volume":"442","author":"So","year":"2012","journal-title":"Biochem J."},{"issue":"1","key":"10.1111\/ajt.15216_bib49","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-00982-x","article-title":"Regulation of T cell alloimmunity by PI3K\u03b3 and PI3K\u03b4","volume":"8","author":"Uehara","year":"2017","journal-title":"Nat Commun."},{"issue":"5","key":"10.1111\/ajt.15216_bib50","first-page":"1602","article-title":"PI3K\/Akt\/mTOR signaling pathway in cancer stem cells: from basic research to clinical application","volume":"5","author":"Xia","year":"2015","journal-title":"Am J Cancer Res."},{"issue":"4","key":"10.1111\/ajt.15216_bib51","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.cell.2017.07.029","article-title":"The PI3K pathway in human disease","volume":"170","author":"Fruman","year":"2017","journal-title":"Cell."},{"issue":"12","key":"10.1111\/ajt.15216_bib52","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.4161\/cc.24928","article-title":"Induction of prolonged early G1 arrest by CDK4\/CDK6 inhibition reprograms lymphomas for durable PI3K\u03b4 inhibition through PIK3IPI","volume":"12","author":"Chiron","year":"2013","journal-title":"Cell Cycle."},{"issue":"7","key":"10.1111\/ajt.15216_bib53","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s12032-015-0650-7","article-title":"MK-2206 induces apoptosis of AML cells and enhances the cytotoxicity of cytarabine","volume":"32","author":"Lu","year":"2015","journal-title":"Med Oncol."}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.15216","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ajt.15216","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522090669?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522090669?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.15216","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:24:20Z","timestamp":1761629060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522090669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S1600613522090669"],"URL":"https:\/\/doi.org\/10.1111\/ajt.15216","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual blockade of the PI3K\/Akt\/mTOR pathway inhibits posttransplant Epstein-Barr virus B cell lymphomas and promotes allograft survival","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.15216","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}